Julien Taieb

62PUBLICATIONS
251CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Oct 26, 2026
Dual VEGF and PD-(L)1 Blockade: Facts and Hopes.

|Aug 17, 2026
Baseline Circulating and Tumor γδ T Cells and Early Circulating CD8+PD-1+ Expansion Predict Response to Atezolizumab-Bevacizumab in HCC.

|Jul 24, 2026
Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.

|Apr 22, 2026
Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II Trial.

|Oct 30, 2025
Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world study.

Emily Alouani, Julien Taieb, David Tougeron

|Oct 29, 2025
Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective Study.

Quentin Giai Gianetto, Valérie Michel, Thibaut Douché

Pageof 11

Frequent Collaborators

14 joint publications

Thierry André

12 joint publications

David Tougeron

12 joint publications

Pierre Laurent-Puig

11 joint publications

Sara Lonardi